For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221202:nRSB5055Ia&default-theme=true
RNS Number : 5055I Natwest Markets PLC 02 December 2022
NatWest Markets Plc
Publication of Pricing Supplement
The following Pricing Supplement is available for viewing:
Pricing Supplement dated 2 December 2022 (the "Pricing Supplement") for the
NatWest Markets Plc ("NatWest Markets") CHF 220,000,000 2.7825% Notes due 6
December 2027 (ISIN: CH1231312708) (the "Notes") issued under the
£15,000,000,000 Euro Medium Term Note Programme of NatWest Markets (the
"Programme").
The Pricing Supplement contains the final terms of the Notes and must be read
in conjunction with the prospectus dated 7 December 2021 and the supplemental
prospectuses dated 18 February 2022, 17 March 2022, 29 April 2022, 29 July
2022, 26 September 2022 and 28 October 2022 relating to the Programme
(together, the "Prospectus"), which constitute a base prospectus for the
purposes of the Prospectus Regulation (EU) 2017/1129 as it forms part of
domestic law in the UK by virtue of the European Union (Withdrawal) Act 2018,
and the prospectus dated 2 December 2022 prepared by NatWest Markets in
connection with admission of the Notes to trading on the SIX Swiss Exchange
(the "Swiss Prospectus").
To view the Pricing Supplement, please paste the following URLs into the
address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/5055I_1-2022-12-2.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/5055I_1-2022-12-2.pdf)
A copy of the above Pricing Supplement has been submitted to the National
Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)
For further information, please contact:
Mark Anwender
Head of Documentation and Funding
NatWest Treasury Markets
Tel: +44 7385 366760
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Pricing Supplement (when
read together with the information in the Prospectus and the Swiss Prospectus)
may be addressed to and/or targeted at persons who are residents of particular
countries (specified in the Prospectus and the Swiss Prospectus) only and is
not intended for use and should not be relied upon by any person outside these
countries and/or to whom the offer contained in the Pricing Supplement, the
Prospectus and the Swiss Prospectus is not addressed. Prior to relying on the
information contained in the Pricing Supplement, the Prospectus and the Swiss
Prospectus, you must ascertain from the Prospectus and the Swiss Prospectus
whether or not you are part of the intended addressees of the information
contained therein.
Your right to access this service is conditional upon complying with the above
requirement.
NatWest Markets Plc - RR3QWICWWIPCS8A4S074
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PSPFSFFWEEESEDE